US2022213020A1PendingUtilityA1

Synthesis of intermediates for producing prostacyclin derivatives

Assignee: UNITED THERAPEUTICS CORPPriority: Oct 20, 2014Filed: Jan 17, 2022Published: Jul 7, 2022
Est. expiryOct 20, 2034(~8.2 yrs left)· nominal 20-yr term from priority
C07C 69/92C07C 45/78C07C 67/333C07C 2603/14C07C 45/67C07C 45/81C07C 67/343C07C 45/64C07C 69/84C07C 67/31C07C 47/565C07C 45/673C07C 47/575
83
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure provides regioselective methods for synthesizing intermediates useful in making prostacyclin derivatives, such as treprostinil.

Claims

exact text as granted — not AI-modified
1 - 19 . (canceled) 
     
     
         20 . A batch for a pharmaceutical manufacturing method comprising at least 10 g of a compound of formula 3: 
       
         
           
           
               
               
           
         
         wherein X is hydrogen, an alkoxy group or OR.sup.2, wherein R.sup.2 is unsubstituted or substituted aryl, or unsubstituted or substituted benzyl; wherein purity of the compound of formula 3 is at least 96% by weight of the batch. 
       
     
     
         21 . The batch of  claim 20 , which is produced without column chromatography. 
     
     
         22 . The batch of  claim 20 , wherein the purity of the compound of formula 3 is at least 97% by weight of the batch. 
     
     
         23 . The batch of  claim 20 , wherein the purity of the compound of formula 3 is at least 98% by weight of the batch. 
     
     
         24 . The batch of  claim 20 , wherein the purity of the compound of formula 3 is at least 99% by weight of the batch. 
     
     
         25 . The batch of  claim 20 , comprising at least 100 g of a compound of formula 3. 
     
     
         26 . The batch of  claim 20 , comprising at least 200 g of a compound of formula 3. 
     
     
         27 . The batch of  claim 20 , comprising at least 300 g of a compound of formula 3.

Join the waitlist — get patent alerts

Track US2022213020A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.